🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Inhibrx Announces Updated Clinical Data for Ozekibart (INBRX-109) in Ewing Sarcoma

Gillette • November 17, 2026 •
Inhibrx Announces Updated Clinical Data for Ozekibart (INBRX-109) in Ewing Sarcoma
- Ozekibart combination in relapsed/refractory Ewing sarcoma achieves 62.7% ORR;
Source: Gillette News Record | https://www.gillettenewsrecord.com/search/?f=rss&t=article&l=50&s=start_time&sd=desc - Read Original
"Monetize your website or boost your business with Code-Oryx. Join the network today!"
"We build AI or anything ICST"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Output is a realization of Input."